On Friday, iRhythm Technologies hit an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 82, up from 79 the day before.
Risk Management In The Stock Market: How Much Money To Invest Now
This exclusive rating from Investor's Business Daily measures share price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners often have an RS Rating north of 80 as they begin their biggest climbs.
iRhythm Technologies is trying to complete a consolidation with a 128.52 entry. See if the stock can clear the breakout price in heavy trade.
iRhythm Technologies reported 0% EPS growth in the latest quarterly report, while sales growth came in at 24%. The next quarterly numbers are expected on or around May 1.
iRhythm Technologies earns the No. 9 rank among its peers in the Medical-Services industry group. Option Care Health, Hims & Hers Health and Progyny are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
